Properties (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Apligraf_from_Novartis
Dermagraft_from_Advanced_BioHealing |
| gptkbp:CEO |
gptkb:Gary_S._Gilliland
|
| gptkbp:employees |
Approximately 500
|
| gptkbp:focus |
Wound care
Surgical reconstruction |
| gptkbp:founded |
1985
|
| gptkbp:headquarters |
gptkb:Canton,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Organogenesis, Inc.
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:market |
gptkb:United_States
International |
| gptkbp:partnerships |
Research institutions
Various hospitals |
| gptkbp:products |
gptkb:Dermagraft
gptkb:Apligraf |
| gptkbp:regulatoryCompliance |
FDA_approved
|
| gptkbp:research |
Cell therapy
Tissue engineering |
| gptkbp:services |
Regenerative medicine
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:type |
Public Company
|
| gptkbp:website |
www.organogenesis.com
|